Vasculitis - I-Vasculitis
☆ Kwiziphumo zika-2022 ze-Stiftung Warentest ezivela eJamani, ukwaneliseka kwabathengi ngeModelDerm bekungaphantsi kancinci kunokubonisana nge-telemedicine ehlawulweyo.
Okunye ukuphazamiseka kwenkqubo (izifo ezizenzekelayo) ezibandakanya i-vasculitis kufuneka zikhutshwe.
Lo ngumfanekiso oqhelekileyo we-vasculitis yomlenze. Uvavanyo lomchamo lunokwenziwa ukujonga izinto ezingaqhelekanga ekusebenzeni kwezintso.
References
Of the 61 patients studied, hypersensitivity vasculitis (HSV) [23 (37.7%)] and Henoch Schonlein purpura (HSP) [16 (26.2%)] were the two most common forms. Systemic involvement was seen in 32 (52.45%) patients. Drugs were implicated in 12 (19.7%) cases, infections in 7 (11.4%) and connective tissue disorders in 4 (6.5%) cases. No association was seen between history of drug intake and tissue eosinophilia and also between histologically severe vasculitis and clinical severity.
Leukocytoclastic vasculitis luhlobo lokudumba kolusu oluchaphazela imithambo yegazi emincinci kumaleko anzulu wolusu. Inokwenzeka ngaphandle kwesizathu esaziwayo okanye inxulunyaniswe nosulelo, amathumba, izifo ezizimelayo, okanye amayeza. Iimpawu eziqhelekileyo ziquka amabala abomvu okanye amfusa emilenzeni, ukubandakanyeka kwemikhumbi emincinci, kwaye malunga nama-30 ekhulwini kwiimeko, amanye amalungu omzimba nawo ayachaphazeleka. Uninzi lweemeko ziphela ngokwazo kwiiveki ezimbalwa ukuya kwiinyanga. Unyango luyahluka ngokususela kwindlela olunzima ngayo, ukusuka ekunciphiseni ngokuthe ngcembe i-corticosteroids yomlomo ukuya ekusebenziseni amanye amachiza athoba ukudumba ngaphandle kwee-steroids.
Leukocytoclastic vasculitis is a cutaneous, small-vessel vasculitis of the dermal capillaries and venules. This condition can be idiopathic or can be associated with infections, neoplasms, autoimmune disorders, and drugs. Key clinical features of leukocytoclastic vasculitis include palpable purpura on the lower extremity, small vessel involvement, and, in about 30 percent of individuals, extracutaneous involvement. Most cases of idiopathic cutaneous, small vessel vasculitis are self-limited with 90 percent of cases resolving in weeks to months of onset. Otherwise, treatment depends on the severity of disease and can range from an oral corticosteroid taper to various steroid-sparing immunosuppressive agents.
Leukocytoclastic vasculitis is a cutaneous, small-vessel vasculitis of the dermal capillaries and venules. This condition can be idiopathic or can be associated with infections, neoplasms, autoimmune disorders, and drugs. Key clinical features of leukocytoclastic vasculitis include palpable purpura on the lower extremity, small vessel involvement, and, in about 30 percent of individuals, extracutaneous involvement. Most cases of idiopathic cutaneous, small vessel vasculitis are self-limited with 90 percent of cases resolving in weeks to months of onset. Otherwise, treatment depends on the severity of disease and can range from an oral corticosteroid taper to various steroid-sparing immunosuppressive agents.
○ Uxilongo
I-Vasculitis ekhawulelwe eluswini inokuphucula ngokuhamba kwexesha. Nangona kunjalo, iimvavanyo zegazi kunye nomchamo zinokwenziwa ukufumanisa ukuphazamiseka kwenkqubo okanye i-autoimmune.
○ Unyango ― OTC Amachiza
Ukuba i-vasculitis inqunyelwe esikhumbeni ngaphandle kokuhlaselwa kwamanye amalungu, i-ointment ye-steroid ingasetyenziswa.
#OTC steroid ointment